Results 21 to 30 of about 22,336 (265)
microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review
Oncotarget, 2018 Esophageal adenocarcinoma (EAC) is a highly aggressive malignancy that develops from Barrett's esophagus (BE), an intestinal metaplasia of the distal esophagus. microRNAs (miRNAs), short non-coding regulatory RNAs, are frequently dysregulated in BE and are thought to play key roles in the onset of BE and its progression to EAC.
Clark, Reilly J. +3 more
openaire +5 more sources
Molecular Cancer, 2006 Background Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is associated with reflux disease. The aim of this study was to assess the expression of bile acid receptors in the esophagus (normal, esophagitis, Barrett's esophagus and ...
Frossard Jean-Louis +10 more
doaj +1 more source
Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems. [PDF]
, 2013 Gastroesophageal reflux disease (GERD), Barrett's esophagus (BE), graft-versus-host disease (GVHD), and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease are common human gastrointestinal diseases that share inflammation as a key
Bortner, James D +6 more
core +2 more sources
Journal of Patient-Centered Research and Reviews, 2017 Background: Current surveillance guidelines for identifying patients with Barrett’s esophagus (BE) at high risk of progressing to esophageal adenocarcinoma (EAC) are considered inefficient because less than 1% of all BE patients are likely to develop EAC.
Hao, Jing +2 more
openaire +3 more sources
Sex steroid hormones in relation to Barrett’s esophagus: An analysis of the FINBAR Study [PDF]
, 2017 Previously we observed strong positive associations between circulating concentrations of free testosterone and free dihydrotestosterone (DHT) in relation to Barrett’s esophagus in a US male military population.
Abnet, Christian C +12 more
core +1 more source
Review: Diagnosis and management of Barrett’s esophagus for the endoscopist
Therapeutic Advances in Gastroenterology, 2010 In Barrett’s esophagus, the stratified squamous epithelium lining the esophagus is replaced by specialized intestinal-type columnar epithelium. The prevalence of Barrett’s esophagus has ranged from 0.9% to 4.5%.
Sagar S. Garud +3 more
doaj +1 more source
Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico
Revista de Gastroenterología de México (English Edition), 2018 Introduction: The prevalence of Barrett's esophagus has been calculated at between 1.3 and 1.6%. There is little information with respect to this in Mexico.
F. Valdovinos-Andraca +7 more
doaj +1 more source
Molecular & Cellular Proteomics, 2018 Esophageal adenocarcinoma (EAC) is thought to develop from asymptomatic Barrett's esophagus (BE) with a low annual rate of conversion. Current endoscopy surveillance of BE patients is probably not cost-effective. Previously, we discovered serum glycoprotein biomarker candidates which could discriminate BE patients from EAC.
David I. Watson +17 more
openaire +3 more sources
The Oxidative Damage and Inflammation Mechanisms in GERD-Induced Barrett’s Esophagus
Frontiers in Cell and Developmental Biology, 2022 Barrett’s esophagus is a major complication of gastro-esophageal reflux disease and an important precursor lesion for the development of Barrett’s metaplasia and esophageal adenocarcinoma.
Deqiang Han, Deqiang Han, Chao Zhang
doaj +1 more source
Gastroesophageal reflux disease and tooth erosion [PDF]
, 2011 The increasing prevalence of gastroesophageal reflux disease (GERD) in children and adults, and of “silent refluxers” in particular, increases the responsibility of dentists to be alert to this potentially severe condition when observing unexplained ...
Kaidonis, J., Ranjitkar, S., Smales, R.
core +4 more sources